tirzepatide diabetes type 1 equally effective for early-onset or later-onset 2 Tirzepatide for the treatment of
Description
Mounjaro (tirzepatide) can be used safely with prednisone, but patients should be monitored for potential side effects, particularly gastrointestinal symptom...

Consult your healthcare provider before use to determine if this medication is suitable for your condition

Support GLP-1 medication advocacy with this empowering design

Written By: Divyanjali Godage BPharmReviewed By: Pharmacally Editorial Team The OASIS-4 phase 3 trial conducted by Novo Nordisk and published in the New England Journal of Medicine shows that once-daily oral semaglutide 25 mg produces clinically significant weight loss (mean weight loss 13.6% vs 2.2% with placebo at week 64)
GRADE: LOW certainty)

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity @NEJM #ADA2024
